Drug companies also have provided funds as part of efforts to investigate biological markers of disease.

WSJ: Twins Health Registry Is Treasure Trove for Medical Research

He's hoping to learn more about the types of patients the drugs might be useful for, and whether there are any biological markers that would help in identifying the right patients.

WSJ: For Alzheimer's, a Fork in the Road